“…For this reason, the biological screening was expanded to evaluate the antimicrobial activity of alkenes 24a–d and diastereoisomeric mixtures of isoxazolidines ( cis - 20a / trans - 20a (10:90), cis - 20b / trans - 20b (8:92), cis - 20c / trans - 20c (6:94), cis - 20d / trans - 20d (10:90), cis - 21a / trans - 21a (10:90), cis - 21b / trans - 21b (15:85), cis - 21c / trans - 21c (10:90), and cis - 21d / trans - 21d (15:85)) towards selected bacterial strains ( E. faecalis ATCC 29212, S. aureus ATCC 2593, B. cereus PCM 1948, E. coli ATCC 25922, and P. aeruginosa ATCC 27853) and two fungal strains (C. albicans ATCC 10241 and A. brasiliensis ATCC 16404). Previous studies have shown that compounds containing a substituted quinazoline-2,4-dione moiety exhibit promising activity against Gram-negative and Gram-positive bacteria and fungi [ 9 , 23 , 24 , 25 ]. The antimicrobial activity was expressed as the MIC, minimal inhibitory concentrations, and the MBC, minimal bactericidal concentrations.…”